Resumen
Although the 5q- syndrome is common in both de novo and treatment related myelodysplastic syndrome (MDS) and the World Health Organization defined 5q- syndrome as a specific type of MDS, it is less common in acute myelogenous leukemia (AML). Recently, it was suggested that AML with diploidy/tetraploidy and/or 5q alterations may be associated with the cryptic translocation, t(7;21)(p22;q22) resulting in RUNX1-USP42 gene fusion and this association may have been underestimated. Here, we report another case of de novo AML with cryptic t(7;21)(p22;q22) associated with a 5q deletion.
Idioma original | English (US) |
---|---|
Páginas (desde-hasta) | 30-34 |
Número de páginas | 5 |
Publicación | Cancer Genetics |
Volumen | 262-263 |
DOI | |
Estado | Published - abr 2022 |
ASJC Scopus subject areas
- Genetics
- Molecular Biology
- Cancer Research